P

Pharmala Biotech Holdings
MDMA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CA$14.27M
EV
-
Shares Outstanding
105.68M
Beta
1.39

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E undefinedE
-
P/Revenue undefinedE
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Pharmala Biotech Holdings Inc.

gainify

P

Pharmala Biotech Holdings Inc.

MDMA

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand na...

Sector

Healthcare

Industry

Biotechnology

CEO

Kadysh, Nicholas

Employees

IPO Date

2022-01-11

Headquarters

1055 West Georgia Street P.O. Box 11117, Vancouver, British Columbia, V6E 4N7, Canada

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on Threads
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.